Emergex Vaccines Holding Limited, a biotechnology company pioneering a new approach to synthetic vaccine development in the field of infectious diseases, announces the appointment of Athanasios Papadopoulos, MD, as Chief Medical Officer, effective 1st March 2019.
February 27, 2019
· 4 min read